MedTrace Logo

Ultrasound Guided TAP Block for Postoperative Analgesia After Abdominal Surgery.

NCT02976597 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-12-31

No results posted yet for this study

Summary

Transversus abdominis plane (TAP) block is a novel type of peripheral nerve block that involves innervations of the anterolateral abdominal wall derived from T6-L1.It provides adequate post-operative pain relieve following the various abdominal surgeries. Theoretically, TAP block may replace the need for epidural analgesia after abdominal operations. The oblique subcostal approach of the TAP (OSTAP) block, which was de¬scribed by (Hebbard et al, 2010) , has been reported to provide analgesia to the entire anterior abdomen.

Conditions

  • Postoperative Pain

Interventions

DRUG

Bupivacaine 0.25% 20ml on each side Sonar guided TAB

Bupivacaine 0.25% 20ml on each side Sonar guided TAP block. After careful aspiration injection of 20ml of 0.25% bupivacaine will be performed and hypoechoic layer will be detected on ultrasound then the maneuver will be repeated on the other side

DRUG

Morphine 10mg

Morphine 10mg will be added to bupivacaine in sonar guided- TAP block divided into 5mg on each side.

DRUG

Morphine 15mg

Morphine 15mg will be added to bupivacaine in sonar guided- TAP block divided into 7.5mg on each side.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hala S Abdel-Ghaffar, MD · Assisstant professor in anesthesia and intensive care, faculty of medicine, Assiut university, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-06-30
Completion
2018-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02976597 on ClinicalTrials.gov